55 completed, 13 unknown, 6 recruiting, 6 terminated. 90 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 90 | Completed 55, Unknown 13, Recruiting 6, Terminated 6, Not yet recruiting 5, Active not recruiting 2, Withdrawn 2, Enrolling by invitation 1 |
Follow Doxycycline: new trials by email Literature Review of Doxycycline trials Research Report on Doxycycline
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Doxycycline Boosted Therapy in Lyme Borreliosis: DoBo Study. Hydroxychloroquin, Placebo, Doxycycline - Lyme Borreliosis, Nervous System | Phase 4 | Not yet recruiting | Radboud University Medical Center | 50 | 2027-03-01 | 2026-08-27 |
| A Randomized Controlled Trial of Doxycycline Post Exposure Prophylaxis to Prevent Incident Bacterial STIs Among Women in the United States Doxycycline, Standard of Care (SOC) - Chlamydia Females, Gonorrhea Female | Phase 4 | Not yet recruiting | Tulane University | 519 | 2027-01-01 | 2026-07-15 |
| These Studies That Evaluated the Efficacy of Antibiotics for Leptospirosis Treatment. Doxycycline, Placebo - Leptospirosis, Chemoprophylaxis | Phase 4 | Not yet recruiting | Chulalongkorn University | 1000 | 2026-11-01 | 2026-10-08 |
| Clinical and Radiographic Evaluation of Doxycycline and Atorvastatin Loaded Chitosan Nanoparticles as an Adjunctive to Scaling and Root Planning in the Management of Chronic Periodontitis. A Randomized Controlled Clinical Trial. Doxycycline and Atorvastatin loaded Chitosan nanoparticles local drug - Chronic Periodontitis | Phase 4 | Not yet recruiting | Fayoum University | 80 | 2026-06-01 | 2026-06-08 |
| Comparing Sarecycline and Doxycycline Effects on the Skin and Gut Bacteria in Acne. Sarecycline, Doxycycline - Acne Vulgaris | Phase 4 | Recruiting | Integrative Skin Science and Research | 30 | 2026-04-20 | 2026-04-22 |
| Doxycycline vs. Macrolide for MRMP (DOMINO) Doxycycline, Azithromycin - Mycoplasma Pneumoniae, Mycoplasma Pneumoniae Pneumonia | Phase 4 | Not yet recruiting | Young June Choe | 208 | 2026-03-01 | 2025-12-29 |
| Got Doxy- 'Flipping the Script' on STI PEP Doxycycline monohydrate 200 mg, Observation - Sexually Transmitted Infections (STI) | Phase 4 | Recruiting | Emory University | 200 | 2025-10-13 | 2026-04-30 |
| The Efficacy of Doxycycline Post Exposure Prophylaxis for Preventing STIs Among MSM in Bangkok, Thailand. Doxycycline (200mg/day) - Syphilis Infection, Gonorrhea | Phase 4 | Recruiting | Bangrak STIs Center | 400 | 2025-10-06 | 2026-02-09 |
| Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams Doxycycline, Azithromycin - Community-acquired Pneumonia | Phase 4 | Recruiting | Mayo Clinic | 1120 | 2025-09-15 | 2026-09-24 |
| Efficacy of Oral Metformin vs Oral Doxycycline in Treating Acne Vulgaris oral metformin, Oral doxycycline - Acne Vulgaris on the Face, Acne Vulgaris | Phase 4 | Completed | Ghurki Trust and Teaching Hospital | 68 | 2025-02-15 | 2026-01-22 |
| Daily Doxycycline to Inform Sexually Transmitted Infection Prophylaxis Regimens Doxycycline - Sexually Transmitted Infection | Phase 4 | Completed | Emory University | 24 | 2024-09-13 | 2026-05-01 |
| Weekly Doxycycline DOT for STI Prevention Among Cisgender Women Taking HIV PrEP in Kisumu, Kenya Doxycycline - STI | Phase 4 | Completed | University of Washington | 60 | 2024-08-13 | 2026-04-13 |
| An Oral Doxycycline Regimen to Prevent Bacteremia Following Dental Procedures Clindamycin, Doxycycline - Bacteremia, Endocarditis | Phase 4 | Unknown | University of Santiago de Compostela | 150 | 2024-07-15 | 2024-06-17 |
| A Study of Doxycycline to Treat Chlamydial Infection Doxycycline, Placebo - Chlamydial Infection | Phase 4 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 526 | 2024-01-19 | 2026-11-10 |
| Comparing Oral Versus Parenteral Antimicrobial Therapy Amoxicillin, amoxicillin-clavulanate, cefadroxil, cefpodoxime, cefalexin, ciprofloxacin, delafloxacin, doxycycline, levofloxacin, linezolid, Ampicillin, ampicillin-sulbactam, cefazolin, cefepime, ceftaroline, ceftazidime, ceftazidime-avibactam, dalbavancin, daptomycin, ertapenem - Endovascular Infection, Bone and Joint Infection | Phase 4 | Terminated | West Virginia University | 94 | 2023-08-04 | 2025-08-26 |
| Ocular Rosacea Biome Study Doxycycline 40 MG ( 20mg twice daily), Doxycycline 200 MG ( 100 mg twice daily), Placebo - Ocular Rosacea, Antimicrobial Resistance | Phase 4 | Completed | University of California, San Francisco | 46 | 2023-06-22 | 2026-10-27 |
| Doxycycline for Helicobacter Pylori Rescue Treatment Esomeprazole, Bismuth Potassium Citrate, Tetracycline - Helicobacter Pylori Infection | Phase 4 | Recruiting | Shanghai Jiao Tong University School of Medicine | 368 | 2023-06-20 | 2024-12-30 |
| Doxy-Post-exposure Prophylaxis Doxycycline - Sexually Transmitted Diseases | Phase 4 | Completed | Emory University | 45 | 2023-05-31 | 2025-09-11 |
| Treatment Responses of Early Syphilis to Ceftriaxone Plus Doxycycline Doxycycline, Ceftriaxone, benzathine penicillin G - Early Syphilis | Phase 4 | Terminated | National Taiwan University Hospital | 109 | 2023-03-10 | 2026-02-25 |
| Comparative Effectiveness Study of Spironolactone Versus Doxycycline for Acne Spironolactone, Doxycycline Hyclate - Acne | Phase 4 | Active not recruiting | University of Pennsylvania | 350 | 2022-03-30 | 2026-08-25 |
Showing 20 of 90. Sign in to see all of them.
Acne Vulgaris (10) · Sexually Transmitted Diseases (10) · Rosacea (8) · Gonorrhea (4) · Infections (4) · Syphilis (4) · COVID-19 (3) · Chlamydia Infections (3) · Pulmonary Disease, Chronic Obstructive (3) · Acquired Immunodeficiency Syndrome (2) · Borrelia Infections (2) · Community-Acquired Pneumonia (2) · Diabetes Mellitus (2) · Diabetes Mellitus, Type 2 (2) · Glossitis, Benign Migratory (2)
Galderma R&D (7) · Emory University (5) · Radboud University Medical Center (3) · British Columbia Centre for Disease Control (2) · Damascus Hospital (2) · Derm Research, PLLC (2) · Mayo Clinic (2) · Medical Center Alkmaar (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Shanghai Zhongshan Hospital (2) · University of Washington (2) · Bangrak STIs Center (1) · Bulovka Hospital (1) · Chulalongkorn University (1) · CollaGenex Pharmaceuticals (1)
United States (43) · Canada (5) · China (5) · Netherlands (4) · Kenya (3) · Egypt (2) · France (2) · India (2) · Israel (2) · South Korea (2) · Syria (2) · Thailand (2) · Austria (1) · Brazil (1) · Cameroon (1)
Colleen Kelley, MD, MPH (4) · Ronald W Gottschalk, MD (3) · Marouf M Alhalabi, MD (2) · Taotao Liu, MD (2) · Troy Grennan, MD (2) · Adam Zanation, MD (1) · Alina Tone, MD (1) · Alireza Minagar, MD (1) · Amy J McMichael, MD (1) · Angelo Secci, MD (1) · Arie Levine, MD (1) · Arif R. Sarwari, MD, MSc, MBA (1) · Assoc. Prof. Daniel Paris (1) · Avni Thakore, MD (1)
PMID 41701614, PMID 38118022, PMID 10738419, PMID 11296335, PMID 11383749, PMID 11438138, PMID 12050508, PMID 15201781, PMID 15232785, PMID 15917525, PMID 15986343, PMID 16979286, PMID 17029130, PMID 17321157, PMID 18052736, PMID 18071030, PMID 18165398, PMID 19875685, PMID 19884021, PMID 20110457, PMID 20489573, PMID 20576731, PMID 20645521, PMID 21070486, PMID 21167743, PMID 21240577, PMID 21398284, PMID 22024822, PMID 22385260, PMID 22668581, PMID 22707212, PMID 22805273, PMID 22981447, PMID 23025537, PMID 23459495, PMID 24059744, PMID 24066290, PMID 24277028, PMID 24421044, PMID 25350566, PMID 25414157, PMID 25572886, PMID 25585069, PMID 25637520, PMID 25801708, PMID 25870333, PMID 26220080, PMID 26283670, PMID 26616678, PMID 26691247
R01AI145971 (2), 2009 (1), 2025 (1), 5UM1AI148684-03 (1), M01RR000827 (1), P20RR017696 (1), P30DK063491 (1), R01AI192319 (1), R01MH123724 (1), R61HL183016 (1), U01AR079752 (1)